Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Current Leases (2016 - 2025)

Pharma-Bio Serv (PBSV) has disclosed Current Leases for 15 consecutive years, with $28834.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Leases fell 82.55% year-over-year to $28834.0, compared with a TTM value of $28834.0 through Oct 2025, down 82.55%, and an annual FY2025 reading of $28834.0, down 82.55% over the prior year.
  • Current Leases was $28834.0 for Q4 2025 at Pharma-Bio Serv, down from $71362.0 in the prior quarter.
  • Across five years, Current Leases topped out at $166637.0 in Q1 2021 and bottomed at $28834.0 in Q4 2025.
  • Average Current Leases over 5 years is $135795.5, with a median of $145090.5 recorded in 2023.
  • The sharpest move saw Current Leases rose 8.37% in 2021, then tumbled 82.55% in 2025.
  • Year by year, Current Leases stood at $130060.0 in 2021, then rose by 8.3% to $140855.0 in 2022, then grew by 8.25% to $152474.0 in 2023, then grew by 8.35% to $165201.0 in 2024, then crashed by 82.55% to $28834.0 in 2025.
  • Business Quant data shows Current Leases for PBSV at $28834.0 in Q4 2025, $71362.0 in Q3 2025, and $113044.0 in Q2 2025.